Eosinophilic Granulomatosis with Polyangiitis
Eosinophilic Granulomatosis with Polyangiitis clinical programs
Phase 1/2 and later readouts in Eosinophilic Granulomatosis with Polyangiitis, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Eosinophilic Granulomatosis with Polyangiitis, so this list is not complete.
Market size not yet sourced. How markets are sized ↗